Low-dose intralesional injection of 5-fluorouracil and triamcinolone reduces tissue resident memory T cells in chronic eczema

Figure 3 Clinical responses of the localized lesions of chronic eczema to intralesional treatment with low-dose 5-FU+TA and TA at 2 wk after treatment. (A) Mean atopic dermatitis severity index (ADSI) scores before and 2 wk after treatment. (B) A number of patients who achieved cure, excellent response, and good response 2 wk after treatment with 5-FU+TA or TA. (C) A number of patients who experienced relapse after treatment with 5-FU+TA (n = 4) or TA (n = 25) during 1-year follow-up. (^bP < 0.01). 5-FU: 5-fluorouracil; TA: triamcinolone.